Accipiter LIFE Sciences FUND Offshore Ltd. files SEC Form 4 disclosures for ORCHID CELLMARK INC. They have made 5 open-market trades across 3 companies since 2008, most recently 2016-11-14.
CIK 0001214706
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
4 open-market purchases totalling $858K since 2008, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FELP | SELL | 2016-11-09 | 2016-11-14 | $7.15 | $7.9M | -5.2% | -10.3% | -6.9% |
| FELP | BUY | 2015-12-10 | 2015-12-14 | $2.58 | $379K | -40.1% | -40.1% | -34.7% |
| EMAG | BUY | 2008-12-02 | 2008-12-04 | $2.50 | $138K | N/A | N/A | N/A |
| EMAG | BUY | 2008-11-26 | 2008-12-01 | $2.51 | $176K | N/A | N/A | N/A |
| ORCH | BUY | 2008-10-06 | 2008-10-08 | $2.03 | $165K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.